Full data view for gene LDLR

Information The variants shown are described using the NM_000527.4 transcript reference sequence.

5 entries on 1 page. Showing entries 1 - 5.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

P-domain     

Enzyme activity     

Predict-BioInf     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+?/+? 1 c.-120C>T r.(=) p.(=) TATA box/SP1 binding site 3% of WT promoter activity (luciferase assay) conservation: 13/13 conservation {PMID25248394:Khamis et al European Journal of Human Genetics (2015) 23, 790–795} Parent #1 ACGS likely pathogenic g.11200105C>T g.11089429C>T Hobb’s -27C>T - LDLR_001115 predicted reduced transcription; co-segregated with FH in 3 siblings, father not available on not present in mother; Not present in 50 normal controls PubMed: Francova 2004 - - Germline - - - - - DNA SEQ - - FH - PubMed: Francova 2004 - - - Czech Republic CZ - - - - 1 Sarah Leigh
+?/+? 1 c.-120C>T r.(=) p.(=) TATA box/SP1 binding site 3% of WT promoter activity (luciferase assay) conservation: 13/13 conservation {PMID25248394:Khamis et al European Journal of Human Genetics (2015) 23, 790–795} Parent #1 ACGS likely pathogenic g.11200105C>T g.11089429C>T Hobb’s -27C>T - LDLR_001115 predicted reduced transcription; co-segregated with FH in 3 siblings, father not available on not present in mother; Not present in 50 normal controls PubMed: Francova 2004 - - Germline - - - - - DNA SEQ - - FH - PubMed: Francova 2004 - - - Czech Republic CZ - - - - 1 Sarah Leigh
+?/+? 1 c.-120C>T r.(=) p.(=) TATA box/SP1 binding site 3% of WT promoter activity (luciferase assay) conservation: 13/13 conservation {PMID25248394:Khamis et al European Journal of Human Genetics (2015) 23, 790–795} Parent #1 ACGS likely pathogenic g.11200105C>T g.11089429C>T Hobb’s -27C>T - LDLR_001115 predicted reduced transcription; co-segregated with FH in 3 siblings, father not available on not present in mother; Not present in 50 normal controls PubMed: Francova 2004 - - Germline - - - - - DNA SEQ - - FH - PubMed: Francova 2004 - - - Czech Republic CZ - - - - 1 Sarah Leigh
+?/+? 1 c.-120C>T r.(=) p.(=) TATA box/SP1 binding site 3% of WT promoter activity (luciferase assay) conservation: 13/13 conservation {PMID25248394:Khamis et al European Journal of Human Genetics (2015) 23, 790–795} Parent #1 ACGS likely pathogenic g.11200105C>T g.11089429C>T Hobb’s -27C>T - LDLR_001115 prediction reduced transcription PubMed: Alonso 2009 - - Germline - - - - - DNA SEQ - - FH - PubMed: Alonso 2009 - - - Spain ES - - - - 1 Sarah Leigh
+?/. - c.-120C>T r.(?) p.(=) - - - Unknown - likely pathogenic g.11200105C>T g.11089429C>T LDLR(NM_000527.5):c.-120C>T - LDLR_001115 VKGL data sharing initiative Nederland - - - CLASSIFICATION record - - - - - - - - - - - - - - - - - - - - - - -
Legend   How to query  


Screenscraping/webscraping (downloading large amounts of data using scripts) is strictly prohibited.
Use our APIs to retrieve data.